SNSE- Sensei Biotherapeutics, Inc.

Name: Sensei Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Sensei Biotherapeutics, Inc. (SNSE) has 9 insiders with recent SEC Form 4 filings, including 22 buys and 0 sells. SNSE is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
COO	Parikh Anand Kiran	1.24M	$29.00M	-
?	Cambrian Biopharma Inc	155.6K	$3.64M	-
Other	Craver Josiah	80.0K	$1.87M	-
Dir	Donenberg Phillip B.	23.1K	$540.5K	-
Dir	Holmen Bob	19.0K	$444.6K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 11, 2022	Peyer James	Director, 10% Owner	Buy	17,500	$4.45	$77,900.00	+0.2%	-64.1%	-66.2%
Feb 8, 2022	Peyer James	Director, 10% Owner	Buy	30,000	$4.53	$135,800.00	+0.2%	-64.4%	-63.3%
Feb 8, 2022	Cambrian Biopharma Inc	10% Owner	Buy	30,000	$4.53	$135,800.00	+0.2%	-64.4%	-63.3%
Jan 28, 2022	Cambrian Biopharma Inc	10% Owner	Buy	15,000	$4.26	$63,849.00	+0.1%	-62.9%	-66.7%
Jan 28, 2022	Peyer James	Director, 10% Owner	Buy	15,000	$4.26	$63,849.00	+0.1%	-62.9%	-66.7%
Jan 26, 2022	Peyer James	Director, 10% Owner	Buy	50,000	$4.72	$235,824.00	+0.5%	-60.7%	-66.9%
Jan 26, 2022	Cambrian Biopharma Inc	10% Owner	Buy	50,000	$4.72	$235,824.00	+0.5%	-60.7%	-66.9%
Jan 24, 2022	Cambrian Biopharma Inc	10% Owner	Buy	47,410	$4.82	$228,528.65	+0.5%	-63.1%	-71.6%
Jan 24, 2022	Peyer James	Director, 10% Owner	Buy	47,410	$4.82	$228,528.65	+0.5%	-63.1%	-71.6%
Jan 20, 2022	Peyer James	Director, 10% Owner	Buy	30,244	$5.10	$154,312.68	+0.3%	-62.2%	-70.1%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC